HS BioLabs, the UK based molecular diagnostics company, expands into Europe by entering into an exclusive distribution agreement with 3B BlackBio for the CE-marked qPCR range of TRUPCR kits.
The newly signed agreement extends the territories from the initial agreement signed in July 2019, which was for UK and Ireland.
With this new partnership, HS BioLabs secures exclusive rights to distribute the TRUPCR range of qPCR products throughout Europe for oncology, infectious disease and coagulation.
HS BioLabs will begin selling TRUPCR across select markets in the European region. Additional markets will be included with the aim of HS BioLabs becoming the sole distributor across all European markets by mid 2021.
Having already displaced a number of global diagnostic suppliers in the UK with TRUCPCR, HS BioLabs is set to replicate the same success throughout Europe.
The kits offer significant advantages to end users by being simple to use, robust, highly sensitive as well as able to work on a wide range of Real-time PCR machines.
Dhirendra Dubey, CEO of 3B BlackBio, said: “We are very pleased to have established this agreement with HS BioLabs, whose track record of successfully marketing molecular diagnostic products gives us confidence that they are the best partner for our TRUPCR range.”
Harminder Singh, MD of HS BioLabs, said: “We are committed to delivering high quality molecular diagnostic products to improve laboratory testing and workflows. This agreement builds on our extensive knowledge and experience of molecular diagnostics. We are excited to expand into Europe and grow our team and infrastructure. We look forward to a mutually beneficial and successful partnership with 3B BlackBio.”
